Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
Chinese PLA General Hospital · Tokyo National Hospital · +26 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
283
total citations
- FWCI
- 83.05
- Percentile
- 100%
- References
- 32
Citations per year
Authors
24Topics & keywords
Topics
Keywords
- Medicine
- Chemotherapy
- Internal medicine
- Placebo
- Performance status
- Capecitabine
- Oncology
- Gastroenterology
UN Sustainable Development Goals
- No poverty
No related works found for this paper.